Unraveling the early events of amyloid-ß protein (Aß) aggregation: Techniques for the determination of Aβ aggregate size

International Journal of Molecular Sciences

Volumn 13, Issue 3, 2012, Pages 3038-3072

  Elizabeth Pryor, N ^a   Moss, Melissa A ^b   Hestekin, Christa N ^a  

^a 3202 Bell Engineering Center   (United States)

^b University of South Carolina   (United States)

Author keywords

Amyloid; Capillary electrophoresis; Centrifugation; Fluorescence correlation spectroscopy; Light scattering; Mass spectrometry; Oligomer; Polyacrylamide gel electrophoresis; Size exclusion chromatography; Western blotting

Indexed keywords

AMYLOID BETA PROTEIN; OLIGOMER; PROTEIN AGGREGATE;

ALZHEIMER DISEASE; ANIMAL CELL; ASYMMETRIC FIELD FLOW FRACTIONATION; CAPILLARY ELECTROPHORESIS; CENTRIFUGATION; CONTROLLED STUDY; CRITICAL MICELLE CONCENTRATION; DOT HYBRIDIZATION; DYNAMIC LIGHT SCATTERING; ELECTROSPRAY MASS SPECTROMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIELD FLOW FRACTIONATION; FLUORESCENCE ANALYSIS; FLUORESCENCE CORRELATION SPECTROSCOPY; GEL PERMEATION CHROMATOGRAPHY; INTERMETHOD COMPARISON; ION MOBILITY SPECTROMETRY; LASER INDUCED FLUORESCENCE; LIGHT ABSORPTION; LIGHT SCATTERING; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROFLUIDIC ANALYSIS; MICROFLUIDIC CAPILLARY ELECTROPHORESIS; MOLECULAR SIZE; MOLECULAR WEIGHT; MULTIANGLE LIGHT SCATTERING; NONHUMAN; OLIGOMERIZATION; PHOTOINDUCED CROSS LINKING OF UNMODIFIED PROTEINS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROCESS OPTIMIZATION; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN CROSS LINKING; REVIEW; SEDIMENTATION; WESTERN BLOTTING; CHEMISTRY; DISEASE COURSE; HUMAN; METABOLISM; PARTICLE SIZE; PROTEIN MULTIMERIZATION; PROTEIN QUATERNARY STRUCTURE; PROTEINOSIS; RADIATION SCATTERING; SIZE EXCLUSION CHROMATOGRAPHY; SPECTROFLUOROMETRY;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BLOTTING, WESTERN; CHROMATOGRAPHY, GEL; DISEASE PROGRESSION; ELECTROPHORESIS, CAPILLARY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; PARTICLE SIZE; PROTEIN AGGREGATES; PROTEIN AGGREGATION, PATHOLOGICAL; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, QUATERNARY; SCATTERING, RADIATION; SPECTROMETRY, FLUORESCENCE; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84858984601     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms13033038     Document Type: Review

References (135)

1. Robinson, J.L.; Geser, F.; Corrada, M.M.; Berlau, D.J.; Arnold, S.E.; Lee, V.M.; Kawas, C.H.; Trojanowski, J.Q. Neocortical and hippocampal amyloid-β and tau measures associate with dementia in the oldest-old. Brain 2011, 134, 3708-3715.
2. Montine, T.J.; Phelps, C.H.; Beach, T.G.; Bigio, E.H.; Cairns, N.J.; Dickson, D.W.; Duyckaerts, C.; Frosch, M.P.; Masliah, E.; Mirra, S.S. et al. National institute on aging-alzheimer's association guidelines for the neuropathologic assessment of alzheimer's disease: A practical approach. Acta Neuropathol. 2012, 123, 1-11.
3. Kagan, B.L.; Jang, H.; Capone, R.; Arce, F.T.; Ramachandran, S.; Lal, R.; Nussinov, R. Antimicrobial properties of amyloid peptides. Mol. Pharm. 2011, in press.
4. Miranker, A.D. Unzipping the mysteries of amyloid fiber formation. Proc. Natl. Acad. Sci. USA 2004, 101, 4335-4336.
5. Murphy, R.M. Peptide aggregation in neurodegenerative disease. Annu. Rev. Biomed. Eng. 2002, 4, 155-174.
6. Selkoe, D.J. Folding proteins in fatal ways. Nature 2003, 426, 900-904.
7. Gazit, E. Mechanisms of amyloid fibril self-assembly and inhibition. Model short peptides as a key research tool. FEBS J. 2005, 272, 5971-5978.
8. Xing, Y.; Higuchi, K. Amyloid fibril proteins. Mech. Ageing Dev. 2002, 123, 1625-1636.
9. Kisilevsky, R. Review: Amyloidogenesis-unquestioned answers and unanswered questions. J. Struct. Biol. 2000, 130, 99-108.
10. Kayed, R.; Head, E.; Sarsoza, F.; Saing, T.; Cotman, C.W.; Necula, M.; Margol, L.; Wu, J.; Breydo, L.; Thompson, J.L. et al. Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers. Mol. Neurodegener. 2007, 2, doi:10.1186/1750-1326-2-18
11. Kayed, R.; Head, E.; Thompson, J.L.; McIntire, T.M.; Milton, S.C.; Cotman, C.W.; Glabe, C.G. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 2003, 300, 486-489.
12. Alzheimer's Association. 2011 alzheimer's disease facts and figures. Alzheimers Dement. 2011, 7, 1-63.
13. Wang, X.; Ding, H. Alzheimer's disease: Epidemiology, genetics, and beyond. Neurosci. Bull. 2008, 24, 105-109.
14. Masters, C.L.; Simms, G.; Weinman, N.A.; Multhaup, G.; McDonald, B.L.; Beyreuther, K. Amyloid Plaque core protein in alzheimer disease and down syndrome. Proc. Natl. Acad. Sci. USA 1985, 82, 4245-4249.
15. Giuffrida, M.L.; Caraci, F.; de Bona, P.; Pappalardo, G.; Nicoletti, F.; Rizzarelli, E.; Copani, A. The monomer state of β-amyloid: Where the alzheimer's disease protein meets physiology. Rev. Neurosci. 2010, 21, 83-93.
16. Teplow, D.B. Structural and kinetic features of amyloid β-protein fibrillogenesis. Int. J. Exp. Clin. Invest. 1998, 5, 121-142.
17. Morris, A.M.; Watzky, M.A.; Finke, R.G. Protein aggregation kinetics, mechanism, and curve-fitting: A review of the literature. biochim. biophys. Acta Proteins Proteomics 2009, 1794, 375-397.
18. Kodali, R.; Wetzel, R. Polymorphism in the intermediates and products of amyloid assembly. Curr. Opin. Struct. Biol. 2007, 17, 48-57.
19. Walsh, D.M.; Selkoe, D.J. Aβ oligomers-A decade of discovery. J. Neurochem. 2007, 101, 1172-1184.
20. Sabate, R.; Estelrich, J. Evidence of the existence of micelles in the fibrillogenesis of β-amyloid peptide. J. Phys. Chem. B 2005, 109, 11027-11032.
21. Lambert, M.P.; Barlow, A.K.; Chromy, B.A.; Edwards, C.; Freed, R.; Liosatos, M.; Morgan, T.E.; Rozovsky, I.; Trommer, B.; Viola, K.L. et al. Diffusible, nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. USA 1998, 95, 6448-6453.
22. Catalano, S.M.; Dodson, E.C.; Henze, D.A.; Joyce, J.G.; Krafft, G.A.; Kinney, G.G. The role of Amyloid-β Derived Diffusible Ligands (ADDLs) in alzheimer's disease. Curr. Top. Med. Chem. (Sharjah, United Arab Emirates) 2006, 6, 597-608.
23. Westlind-Danielsson, A.; Arnerup, G. Spontaneous in vitro formation of supramolecular β- amyloid structures, "βamy Balls", by β-amyloid 1-40 peptide. Biochemistry 2001, 40, 14736-14743.
24. Matsumura, S.; Shinoda, K.; Yamada, M.; Yokojima, S.; Inoue, M.; Ohnishi, T.; Shimada, T.; Kikuchi, K.; Masui, D.; Hashimoto, S. et al. Two distinct amyloid β-protein (Aβ) assembly pathways leading to oligomers and fibrils identified by combined fluorescence correlation spectroscopy, morphology, and toxicity analyses. J. Biol. Chem. 2011, 286, 11555-11562.
25. Walsh, D.; Lomakin, A.; Benedek, G.; Condron, M.; Teplow, D. Amyloid β-protein fibrillogenesis: Detection of a protofibrillar intermediate. J. Biol. Chem. 1997, 272, 22364-22372.
26. Ward, R.; Jennings, K.; Howlett, D. Fractionation and characterization of oligomeric, protofibrillar and fibrillar forms of β-amyloid peptide. Biochem. J. 2000, 348, 137+138+144.
27. Thirumalai, D.; Klimov, D.; Dima, R. Emerging ideas on the molecular basis of protein and peptide aggregation. Curr. Opin. Struct. Biol. 2003, 13, 146-159.
28. Roher, A.E.; Baudry, J.; Chaney, M.O.; Kuo, Y.-M.; Stine, W.B.; Emmerling, M.R. Oligomerization and Fibril Assembly of the Amyloid-β Protein. Biochim. Biophys. Acta Mol. Basis Dis. 2000, 1502, 31-43.
29. Morgan, C.; Colombres, M.; Nunez, M.T.; Inestrosa, N.C. Structure and function of amyloid in alzheimer's disease. Prog. Neurobiol. 2004, 74, 323-349.
30. Barghorn, S.; Nimmrich, V.; Striebinger, A.; Krantz, C.; Keller, P.; Janson, B.; Bahr, M.; Schmidt, M.; Bitner, R.S.; Harlan, J. et al. Globular amyloid β-peptide1-42 oligomer-A homogeneous and stable neuropathological protein in alzheimer's disease. J. Neurochem. 2005, 95, 834-847.
31. Kawooya, J.; Emmons, T.; Gonzalez-DeWhitt, P.; Camp, M.; D'Andrea, S. Electrophoretic mobility of alzheimer's amyloid-β peptides in urea-sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Anal. Biochem. 2003, 323, 103-113.
32. Gursky, O.; Aleshkov, S. Temperature-dependent β-sheet formation in β-amyloid aβ1-40 peptide in water: Uncoupling β-structure folding from aggregation. Biochim. Biophys. Acta BBA Protein Struct. Mol. Enzymol. 2000, 1476, 93-102.
33. Caughey, B.; Lansbury, P.T. Protofibrils, pores, fibrils, and neurodegeneration: Separating the responsible protein aggregates from the innocent bystanders. Annu. Rev. Neurosci. 2003, 26, 267-298.
34. Glabe, C.G. Common mechanisms of amyloid oligomer pathogenesis in degenerative disease. Neurobiol. Aging 2006, 27, 570-575.
35. Roychaudhuri, R.; Yang, M.; Hoshi, M.M.; Teplow, D.B. Amyloid β-protein assembly and alzheimer's disease. J. Biol. Chem. 2009, 284, 4749-4753.
36. Gonzalez-Velasquez, F.J.; Kotarek, J.A.; Moss, M.A. Soluble aggregates of the amyloid-β protein selectively stimulate permeability in human brain microvascular endothelial monolayers. J. Neurochem. 2008, 107, 466-477.
37. Hartley, D.M.; Walsh, D.M.; Ye, C.P.; Diehl, T.; Vasquez, S.; Vassilev, P.M.; Teplow, D.B.; Selkoe, D.J. Protofibrillar intermediates of amyloid β-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J. Neurosci. 1999, 19, 8876-8884.
38. Lesne, S.; Koh, M.T.; Kotilinek, L.; Kayed, R.; Glabe, C.G.; Yang, A.; Gallagher, M.; Ashe, K.H. A specific amyloid-β protein assembly in the brain impairs memory. Nature 2006, 440, 352-357.
39. Walsh, D.M.; Klyubin, I.; Fadeeva, J.V.; Rowan, M.J.; Selkoe, D.J. Amyloid-β oligomers: Their production, toxicity and therapeutic inhibition. Biochem. Soc. Trans. 2002, 30, 552-557.
40. Westerman, M.; Cooper-Blacketer, D.; Mariash, A.; Kotilinek, L.; Kawarabayashi, T.; Younkin, L.; Carlson, G.; Younkin, S.; Ashe, K. The relationship between aβ and memory in the tg2576 mouse model of alzheimer's disease. J. Neurosci. 2002, 22, 1858-1867.
41. Lue, L.F.; Kuo, Y.M.; Roher, A.E.; Brachova, L.; Shen, Y.; Sue, L.; Beach, T.; Kurth, J.H.; Rydel, R.E.; Rogers, J. Soluble amyloid β peptide concentration as a predictor of synaptic change in alzheimer's disease. Am. J. Pathol. 1999, 155, 853-862.
42. Scheff, S.; Price, D.; Schmitt, F.; Mufson, E. Hippocampal synaptic loss in early alzheimer's disease and mild cognitive impairment. Neurobiol. Aging 2006, 27, 1372-1384.
43. Yang, T.; Hsu, C.; Kuo, Y. Cell-derived soluble oligomers of human amyloid-β peptides disturb cellular homeostasis and induce apoptosis in primary hippocampal neurons. J. Neural Transm. 2009, 116, 1561-1569.
44. Bitan, G.; Fradinger, E.A.; Spring, S.M.; Teplow, D.B. Neurotoxic protein oligomers-What you see is not always what you get. Amyloid 2005, 12, 88-95.
45. Ying, Z.; Xin, W.; Jin-Sheng, H.; Fu-Xiang, B.; Wei-Min, S.; Xin-Xian, D.; Xiao-Bo, W.; Yi-Qin, L.; Xian-Xian, Z.; Hong-Gang, H. et al. Preparation and characterization of a monoclonal antibody with high affinity for soluble Aβ oligomers. Hybridoma 2009, 28, 349-354.
46. Satoh, Y.; Hirakura, Y.; Kirino, Y. Beta-amyloid peptides inhibit acetylcholine release from cholinergic presynaptic nerve endings isolated from an electric ray. Neurosci. Lett. 2001, 302, 97-100.
47. Sureshbabu, N.; Kirubagaran, R.; Jayakumar, R. Surfactant-induced conformational transition of amyloid β-peptide. Eur. Biophys. J. 2009, 38, 355-367.
48. Iurascu, M.; Cozma, C.; Tomczyk, N.; Rontree, J.; Desor, M.; Drescher, M.; Przybylski, M. Structural characterization of β-amyloid oligomer-aggregates by ion mobility mass spectrometry and electron spin resonance spectroscopy. Anal. Bioanal. Chem. 2009, 395, 2509-2519.
49. Klug, G.; Losic, D.; Small, D. Beta-amyloid protein oligomers induced by metal ions and acid pH are distinct from those generated by slow spontaneous ageing at neutral pH. Eur. J. Biochem. 2003, 270, 4282-4293.
50. Walsh, D.; Tseng, B.; Rydel, R.; Podlisny, M.; Selkoe, D. The oligomerization of amyloid β-protein begins intracellularly in cells derived from human brain. Biochemistry 2000, 39, 10831-10839.
51. Stine, W.B., Jr.; Dahlgren, K.N.; Krafft, G.A.; LaDu, M.J. In Vitro Characterization of Conditions for Amyloid-β Peptide Oligomerization and Fibrillogenesis. J. Biol. Chem. 2003, 278, 11612-11622.
52. Ryan, D.; Narrow, W.; Federoff, H.; Bowers, W. An Improved Method for Generating Consistent Soluble Amyloid-β Oligomer Preparations for in Vitro Neurotoxicity Studies. J.Neurosci. Method. 2010, 190, 171-179.
53. Dahlgren, K.N.; Manelli, A.M.; Stine, W.B., Jr.; Baker, L.K.; Krafft, G.A.; LaDu, M.J. Oligomeric and Fibrillar Species of Amyloid-β Peptides Differentially Affect Neuronal Viability. J. Biol. Chem. 2002, 277, 32046-32053.
54. Moore, B.; Rangachari, V.; Tay, W.; Milkovic, N.; Rosenberry, T. Biophysical Analyses of Synthetic Amyloid-β(1-42) Aggregates before and After Covalent Cross-Linking. Implications for Deducing the Structure of Endogenous Amyloid-β Oligomers. Biochemistry 2009, 48, 11796-11806.
55. Walsh, D.; Hartley, D.; Condron, M.; Selkoe, D.; Teplow, D. In Vitro studies of Amyloid β-Protein Fibril Assembly and Toxicity Provide Clues to the Aetiology of Flemish Variant (Ala692 → Gly) Alzheimer's Disease. Biochem. J. 2001, 355, 869-877.
56. Gravina, S.A.; Ho, L.; Eckman, C.B.; Long, K.E.; Otvos, L., Jr.; Younkin, L.H.; Suzuki, N.; Younkin, S.G. Amyloid β protein (Aβ) in alzheimer's disease brain. biochemical and immunocytochemical analysis with antibodies specific for forms ending at Aβ40 Or Aβ42(43). J. Biol. Chem. 1995, 270, 7013-7016.
57. Wong, H.E.; Qi, W.; Choi, H.; Fernandez, E.J.; Kwon, I. A safe, blood-brain barrier permeable triphenylmethane dye inhibits amyloid-β neurotoxicity by generating nontoxic aggregates. ACS Chem. Neurosci. 2011, 2, 645-657.
58. Hu, Y.; Su, B.H.; Kim, C.S.; Hernandez, M.; Rostagno, A.; Ghiso, J.; Kim, J.R. A strategy for designing a peptide probe for detection of β-amyloid oligomers. ChemBioChem 2010, 11, 2409-2418.
59. Lambert, M.P.; Velasco, P.T.; Chang, L.; Viola, K.L.; Fernandez, S.; Lacor, P.N.; Khuon, D.; Gong, Y.; Bigio, E.; Shaw, P. et al. Monoclonal antibodies that target pathological assemblies of Aβ. J. Neurochem. 2007, 100, 23-25.
60. Wu, J.W.; Breydo, L.; Isas, J.M.; Lee, J.; Kuznetsov, Y.G.; Langen, R.; Glabe, C. Fibrillar oligomers nucleate the oligomerization of monomeric amyloid β but do not seed fibril formation. J. Biol. Chem. 2010, 285, 6071-6079.
61. Zagorski, M.G.; Barrow, C.J. NMR studies of amyloid β-peptides: Proton assignments, secondary structure, and mechanism of an α-helix-α-sheet conversion for a homologous, 28-residue, N-terminal fragment. Biochemistry 1992, 31, 5621-5631.
62. Bitan, G.; Teplow, D. Rapid photochemical cross-linking-A new tool for studies of metastable, amyloidogenic protein assemblies. Acc. Chem. Res. 2004, 37, 357-364.
63. Fancy, D.S.; Kodadek, T. Chemistry for the analysis of protein-protein interactions: Rapid and efficient cross-linking triggered by long wavelength light. Proc. Natl. Acad. Sci. USA 1999, 96, 6020-6024.
64. Gerardi, R.D.; Barnett, N.W.; Lewis, S.W. Analytical Applications of Tris(2,2'-Bipyridyl) Ruthenium(III) as a Chemiluminescent Reagent. Anal. Chim. Acta 1999, 378, 1-43.
65. Bitan, G.; Kirkitadze, M.; Lomakin, A.; Vollers, S.; Benedek, G.; Teplow, D. Amyloid β-protein (Aβ) assembly: Aβ40 and Aβ42 oligomerize through distinct pathways. Proc. Natl. Acad. Sci. USA 2003, 100, 330-335.
66. Podlisny, M.; Walsh, D.; Selkoe, D. Oligomerization of endogeneous and synthetic amyloid β-protein at nanomolar levels in cell culture and stabilization of monomer by congo red. Biochemistry 1998, 37, 3602-3611.
67. Townsend, M.; Shankar, G.M.; Mehta, T.; Walsh, D.M.; Selkoe, D.J. Effects of secreted oligomers of amyloid β-protein on hippocampal synaptic plasticity: A potent role for trimers. J. Physiol. 2006, 572, 477-492.
68. Zuberovic, A.; Hanrieder, J.; Wetterhall, M. Proteome Profiling of human cerebrospinal fluid: Exploring the potential of capillary electrophoresis with surface modified capillaries for analysis of complex biological samples. Eur. J. Mass Spectrom. 2008, 14, 249-260.
69. Lee, Y.-.L.; Maus, R.; Smith, B.; Winefordner, J. Laser-induced fluorescence detection of a single molecule in a capillary. Anal. Chem. 1994, 66, 4142-4149.
70. Skeidsvoll, J.; Ueland, P. Analysis of double-stranded dna by capillary electrophoresis with laser-induced fluorescence detection using the monomeric dye SYBR green I. Anal. Biochem. 1995, 231, 359-365.
71. Verpillot, R.; Otto, M.; Taverna, M. Simultaneous analysis by capillary electrophoresis of five amyloid peptides as potential biomarkers of alzheimer's disease. J. Chromatogr. A 2008, 1214, 157-164.
72. Sabella, S.; Quaglia, M.; Lanni, C.; Racchi, M.; Govoni, S.; Caccialanza, G.; Calligaro, A.; Bellotti, V.; Lorenzi, E. Capillary electrophoresis studies on the aggregation process of β-amyloid 1-42 and 1-40 peptides. Electrophoresis 2004, 25, 3186-3194.
73. Picou, R.; Kheterpal, I.; Wellman, A.; Minnamreddy, M.; Ku, G.; Gilman, S.D. Analysis of Aβ(1-40) and Aβ(1-42) monomer and fibrils by capillary electrophoresis. J. Chromatogr. B 2011, 879, 627-632.
74. Kato, M.; Kinoshita, H.; Toyo'oka, T. Analytical method for β-amyloid fibrils using ce-laser induced fluorescence and its application to screening for inhibitors of β-amyloid protein aggregation. Anal. Chem. 2007, 79, 4887-4891.
75. Jakeway, S.C.; de Mello, A.J.; Russell, E.L.; Fresenius, J. Miniaturized total analysis systems for biological analysis. Anal. Chem. 2000, 366, 525-539.
76. Chovan, T.; Guttman, A. Microfabricated devices in biotechnology and biochemical processing. Trends Biotechnol. 2002, 20, 116-122.
77. Mohamadi, M.R.; Svobodova, Z.; Verpillot, R.; Esselmann, H.; Wiltfang, J.; Otto, M.; Taverna, M.; Bilkova, Z.; Viovy, J. Microchip electrophoresis profiling of aβ peptides in the cerebrospinal fluid of patients with alzheimer's disease. Anal. Chem. 2010, 82, 7611-7617.
78. Steiner, W.E.; Klopsch, S.J.; English, W.A.; Clowers, B.H.; Hill, H.H. Detection of a chemical warfare agent simulant in various aerosol matrixes by ion mobility time-of-flight mass spectrometry. Anal. Chem. 2005, 77, 4792-4799.
79. Huertas, M.L.; Marty, A.M.; Fontan, J.; Alet, I.; Duffa, G. Measurement of mobility and mass of atmospheric ions. J. Aerosol Sci. 1971, 2, 145-150.
80. Borsdorf, H.; Rudolph, M. Gas-phase ion mobility studies of constitutional isomeric hydrocarbons using different ionization techniques. Int. J. Mass Spectrom. 2001, 208, 67-72.
81. Hill, C.A.; Thomas, C.L.P. Programmable gate delayed ion mobility spectrometry-mass spectrometry: A study with low concentrations of dipropylene-glycol-monomethyl-ether in air. Analyst 2005, 130, 1155-1161.
82. Sielemann, S.; Baumbach, J.I.; Schmidt, H.; Pilzecker, P. Quantitative analysis of benzene, toluene, and m-Xylene with the use of a UV-ion mobility spectrometer. Field Anal. Chem. Technol. 2000, 4, 157-169.
83. Valentine, S.J.; Anderson, J.G.; Ellington, A.D.; Clemmer, D.E. Disulfide-intact and -reduced lysozyme in the gas phase: Conformations and pathways of folding and unfolding. J. Phys. Chem. 1997, 101, 3891-3900.
84. Ells, B.; Barnett, D.A.; Froese, K.; Purves, R.W.; Hrudey, S.; Guevremont, R. Detection of chlorinated and brominated byproducts of drinking water disinfection using electrospray ionization-high-field asymmetric waveform ion mobility spectrometry-mass spectrometry. Anal. Chem. 1999, 71, 4747-4752.
85. Matz, L.M.; Hill, H.H.J. Evaluation of opiate separation by high-resolution electrospray ionization-ion mobility spectrometry/mass spectrometry. Anal. Chem. 2001, 73, 1664-1669.
86. Smith, D.P.; Giles, K.; Bateman, R.H.; Radford, S.E.; Ashcroft, A.E. Monitoring copopulated conformational states fduring protein folding events using electrospray ionization-ion mobility spectrometry-mass spectrometry. J. Am. Soc. Mass Spectrom. 2007, 18, 2180-2190.
87. Gillig, K.J.; Ruotolo, B.; Stone, E.G.; Russell, D.H.; Fuhrer, K.; Gonin, M.; Schultz, A.J. Coupling high-pressure MALDI with ion mobility/orthogonal time-of-flight mass spectrometry. Anal. Chem. 2000, 72, 3965-3971.
88. Woods, A.S.; Koomen, J.M.; Ruotolo, B.T.; Gillig, K.J.; Russel, D.H.; Fuhrer, K.; Gonin, M.; Egan, T.F.; Schultz, J.A. A study of peptide-peptide interactions using MALDI ion mobility o-TOF and ESI mass spectrometry. J. Am. Soc. Mass Spectrom. 2002, 13, 166-169.
89. Steiner, W.E.; Clowers, B.H.; English, W.A.; Hill, H.H.J. Atmospheric pressure matrix-assisted laser desorption/ionization with analysis by ion mobility time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 2004, 18, 882-888.
90. McLean, J.A.; Ruotolo, B.T.; Gillig, K.J.; Russell, D.H. Ion mobility-mass spectrometry: A new paradigm for proteomics. Int. J. Mass Spectrom. 2005, 240, 301-315.3
91. von Helden, G.; Gotts, N.G.; Bowers, M.T. Experimental evidence for the formation of fullerenes by collisional heating of carbon rings in the gas phase. Nature 1993, 363, 60-63.
92. von Helden, G.; Kemper, P.R.; Gotts, N.G.; Bowers, M.T. Isomers of small carbon cluster anions: Linear chains with up to 20 atoms. Science 1993, 259, 1300-1302.
93. Jarrold, M.F.; Constant, V.A. Silicon cluster ions: Evidence for a structural transition. Phys. Rev. Lett. 1991, 67, 2994-2997.
94. Kanu, A.B.; Dwivedi, P.; Tam, M.; Matz, L.; Hill, H.H. Ion mobility-mass spectrometry. J. Mass Spectrom. 2008, 43, 1-22.
95. Maji, S.; Ogorzalek Loo, R.; Inayathullah, M.; Spring, S.; Vollers, S.; Condron, M.; Bitan, G.; Loo, J.; Teplow, D. Amino acid position-specific contributions to amyloid β-protein oligomerization. J. Biol. Chem. 2009, 284, 23580-23591.
96. Oe, T.; Ackermann, B.L.; Inoue, K.; Berna, M.J.; Garner, C.O.; Gelfanova, V.; Dean, R.A.; Siemers, E.R.; Holtzman, D.M.; Farlow, M.R. et al. Quantitative analysis of amyloid? Peptides in cerebrospinal fluid of alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry. Rapid Commun. Mass Spectrom. 2006, 20, 3723-3735.
97. Ashcroft, A. Mass spectrometry and and amyloid problem-how far can we go in the gas phase? J. Am. Soc. Mass Spectrom. 2010, 21, 1087-1096.
98. Palmblad, M.; Westlind-Danielsson, A.; Bergquist, J. Oxidation of methionine 35 attenuates formation of amyloid β-peptide 1-40 oligomers. J. Biol. Chem. 2002, 277, 19506-19510.
99. Clemmer, D.E.; Hudgins, R.R.; Jarrold, M.F. Naked protein conformations: Cytochrome c in the gas phase. J. Am. Chem. Soc. 1995, 117, 10141-10142.
100. Clemmer, D.E.; Jarrold, M.F. Ion mobility measurements and their applications to clusters and biomolecules. J. Mass Spectrom. 1997, 32, 577-592.
101. Henderson, S.C.; Valentine, S.J.; Counterman, A.E.; Clemmer, D.E. ESI/ion trap/ion mobility/ time-of-flight mass spectrometry for rapid and sensitive analysis of biomolecular mixtures. Anal. Chem. 1999, 71, 291-301.
102. Murray, M.; Bernstein, S.; Nyugen, V.; Condron, M.; Teplow, D.; Bowers, M. Amyloid β protein: Aβ40 inhibits Aβ42 oligomerization. J. Am. Chem. Soc. 2009, 131, 6316-6317.
103. Bernstein, S.; Wyttenbach, T.; Baumketner, A.; Shea, J.; Bitan, G.; Teplow, D.; Bowers, M. Amyloid β-protein: Monomer structure and early aggregation states of Aβ42 and its Pro19 alloform. J. Am. Chem. Soc. 2005, 127, 2075-2084.
104. Bernstein, S.; Dupuis, N.; Lazo, N.; Wyttenbach, T.; Condron, M.; Bitan, G.; Teplow, D.; Shea, J.; Ruotolo, B.; Robinson, C. et al. Amyloid-β protein oligomerization and the importance of tetramers and dodecamers in the aetiology of alzheimer's disease. Nat. Chem. 2009, 1, 326-331.
105. Cizas, P.; Budvytyte, R.; Morkuniene, R.; Moldovan, R.; Broccio, M.; Loesche, M.; Niaura, G.; Valincius, G.; Borutaite, V. Size-dependent neurotoxicity of β-amyloid oligomers. Arch. Biochem. Biophys. 2010, 496, 84-92.
106. Tjernberg, L.O.; Pramanik, A.; Bjorling, S.; Thyberg, P.; Thyberg, J.; Nordstedt, C.; Berndt, K.D.; Terenius, L.; Rigler, R. Amyloid β-peptide polymerization studied using fluorescence correlation spectroscopy. Chem. Biol. 1999, 6, 53-62.
107. Garai, K.; Sahoo, B.; Sengupta, P.; Maiti, S. Quasihomogeneous nucleation of amyloid β yields numerical bounds for the critical radius, the surface tension, and the free energy barrier for nucleus formation. J. Chem. Phys. 2008, 128, 045102:1-045102:7.
108. Eigen, M.; Rigler, R. Sorting single molecules: Application to diagnostics and evolutionary biotechnology. Proc. Natl. Acad. Sci. USA 1994, 91, 5740-5747.
109. Garai, K.; Sengupta, P.; Sahoo, B.; Maiti, S. Selective destabilization of soluble amyloid β oligomers by divalent metal ions. Biochem. Biophys. Res. Commun. 2006, 345, 210-215.
110. Funke, S.A.; Birkmann, E.; Henke, F.; Goertz, P.; Lange-Asschenfeldt, C.; Riesner, D.; Willbold, D. Single particle detection of Aβ aggregates associated with alzheimer's disease. Biochem. Biophys. Res. Commun. 2007, 364, 902-907.
111. Godderz, L.J.; Peak, M.M.; Rodgers, K.K. Analysis of biological macromolecular assemblies using static light scattering methods. Curr. Org. Chem. 2005, 9, 899-908.
112. Villari, V.; Micali, N. Light scattering as spectroscopic tool for the study of disperse systems useful in pharmaceutical sciences. J. Pharm. Sci. 2008, 97, 1703-1730.
113. Alexander, M.; Dalgleish, D. Dynamic light scattering techniques and their applications in food science. Food Biophys. 2006, 1, 2-13.
114. Lomakin, A.; Teplow, D.B.; Kirschner, D.A.; Benedek, G.B. Kinetic theory of fibrillogenesis of amyloid β-protein. Proc. Natl. Acad. Sci. USA 1997, 94, 7942-7947.
115. Lomakin, A.; Chung, D.S.; Benedek, G.B.; Kirschner, D.A.; Teplow, D.B. On the nucleation and growth of amyloid β-protein fibrils: Detection of nuclei and quantitation of rate constants. Proc. Natl. Acad. Sci. USA 1996, 93, 1125-1129.
116. Thunecke, M.; Lobbia, A.; Kosciessa, U.; Dyrks, T.; Oakley, A.E.; Turner, J.; Saenger, W.; Georgalis, Y. Aggregation of Aβ alzheimer's disease-related peptide studied by dynamic light scattering. J. Pept. Res. 1998, 52, 509-517.
117. Carrotta, R.; Manno, M.; Bulone, D.; Martorana, V.; San Biagio, P.L. Protofibril Formation of Amyloid β-Protein at Low pH via a Non-Cooperative Elongation Mechanism. J. Biol. Chem. 2005, 280, 30001-30008.
118. Murphy, R.M.; Pallitto, M.M. Probing the kinetics of β-amyloid self-association. J. Struct. Biol. 2000, 130, 109-122.
119. Rambaldi, D.C.; Zattoni, A.; Reschiglian, P.; Colombo, R.; de Lorenzi, E. In vitro amyloid Aβ(1-42) peptide aggregation monitoring by asymmetrical flow field-flow fractionation with multi-angle light scattering detection. Anal. Bioanal. Chem. 2009, 394, 2145-2149.
120. Nichols, M.; Moss, M.; Rosenberry, T. Growth of β-amyloid(1-40) protofibrils by monomer elongation and lateral association. Characterization of distinct products by light scattering and atomic force microscopy. Biochemistry 2002, 41, 6115-6127.
121. Walsh, D.; Hartley, D.; Kusumoto, Y.; Fezoui, Y.; Condron, M.; Lomakin, A.; Benedek, G.; Selkoe, D.; Teplow, D. Amyloid β-protein fibrillogenesis: Structure and biological activity of protofibrillar intermediates. J. Biol. Chem. 1999, 274, 25945-25952.
122. Yohannes, G.; Jussila, M.; Hartonen, K.; Riekkola, M. Asymmetrical flow field-flow fractionation technique for separation and characterization of biopolymers and bioparticles. J. Chromatogr. A 2011, 1218, 4104-4116.
123. Roda, B.; Zattoni, A.; Reschiglian, P.; Moon, M.H.; Mirasoli, M.; Michelini, E.; Roda, A. Field-flow fractionation in bioanalysis: A review of recent trends. Anal. Chim. Acta 2009, 635, 132-143.
124. Mok, Y.; Howlett, G.J. Sedimentation velocity analysis of amyloid oligomers and fibrils. Methods Enzymol. 2006, 413, 199-217.
125. Huang, T.H.J.; Yang, D.; Plaskos, N.P.; Go, S.; Yip, C.M.; Fraser, P.E.; Chakrabartty, A. Structural studies of soluble oligomers of the alzheimer β-amyloid peptide. J. Mol. Biol. 2000, 297, 73-87.
126. Nagel-Steger, L.; Demeler, B.; Meyer-Zaika, W.; Hochdoerffer, K.; Schrader, T.; Willbold, D. Modulation of aggregate size- and shape-distributions of the amyloid-β peptide by a designed β-sheet breaker. Eur. Biophys. J. 2010, 39, 415-422.
127. Paivio, A.; Jarvet, J.; Graslund, A.; Lannfelt, L.; Westlind-Danielsson, A. Unique physicochemical profile of β-amyloid peptide variant Aβ1-40E22G protofibrils: Conceivable neuropathogen in arctic mutant carriers. J. Mol. Biol. 2004, 339, 145-159.
128. Wiberg, H.; Ek, P. Separation and characterization of aggregated species of amyloid-β peptides. Anal. Bioanal. Chem. 2010, 397, 2357-2366.
129. Ahmed, M.; Davis, J.; Aucoin, D.; Sato, T.; Ahuja, S.; Aimoto, S.; Elliott, J.I.; van Nostrand, W.E.; Smith, S.O. Structural conversion of neurotoxic amyloid-β1-42 oligomers to fibrils. Nat. Struct. Mol. Biol. 2010, 17, 561-567.
130. Englund, H.; Sehlin, D.; Johansson, A.; Nilsson, L.N.G.; Gellerfors, P.; Paulie, S.; Lannfelt, L.; Pettersson, F.E. Sensitive ELISA detection of amyloid-β protofibrils in biological samples. J. Neurochem. 2007, 103, 334-345.
131. Zheng, X.; Wang, L.; Zhang, L.; Hong, Y.; Huang, L.; Sha, Y. Separation and analysis of the soluble trimer of Aβ1-40 and its effects on the rise in intracellular calcium. Chin. Sci. Bull. 2006, 51, 830-838.
132. Necula, M.; Kayed, R.; Milton, S.; Glabe, C.G. Small molecule inhibitors of aggregation indicate that amyloid β oligomerization and fibrillization pathways are independent and distinct. J. Biol. Chem. 2007, 282, 10311-10324.
133. Gonzales, A.M.; Orlando, R.A. A sensitive Aβ oligomerization assay for identification of small molecule inhibitors. Open Biotechnol. J. 2009, 3, 108-116.
134. Kamali-Moghaddam, M.; Pettersson, F.E.; Wu, D.; Englund, H.; Darmanis, S.; Lord, A.; Tavoosidana, G.; Sehlin, D.; Gustafsdottir, S.; Nilsson, L.N.G. et al. Sensitive detection of Aβ protofibrils by proximity ligation-Relevance for alzheimer's disease. BMC Neurosci. 2010, 11, doi:10.1186/1471-2202-11-124
135. Stenh, C.; Englund, H.; Lord, A.; Johansson, A.; Almeida, C.G.; Gellerfors, P.; Greengard, P.; Gouras, G.K.; Lannfelt, L.; Nilsson, L.N.G. Amyloid-β oligomers are inefficiently measured by enzyme-linked immunosorbent assay. Ann. Neurol. 2005, 58, 147-150.